SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

12 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 26206.00 millions grew by 21.36 % from Rs. 21593.00 millions.The Company's Net profit for the September 2024 quarter have declined marginally to Rs. 7898.00  millions as against Rs. 8050.00 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 12689.00 millions from 11839.00 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 26206.00 21593.00 21.36 67808.00 51150.00 32.57 108187.00 87316.00 23.90
Other Income 3813.00 6212.00 -38.62 4879.00 7036.00 -30.66 11595.00 8219.00 41.08
PBIDT 12689.00 11839.00 7.18 37484.00 24073.00 55.71 51435.00 30028.00 71.29
Interest 959.00 909.00 5.50 2113.00 1806.00 17.00 3907.00 2782.00 40.44
PBDT 11730.00 10930.00 7.32 35371.00 22267.00 58.85 47442.00 25208.00 88.20
Depreciation 1337.00 1249.00 7.05 2643.00 2461.00 7.40 5044.00 4886.00 3.23
PBT 10393.00 9681.00 7.35 32728.00 19806.00 65.24 42398.00 20322.00 108.63
TAX 2495.00 1631.00 52.97 7822.00 3947.00 98.18 7983.00 5030.00 58.71
Deferred Tax 9.00 -85.00 -110.59 20.00 -133.00 -115.04 -1360.00 412.00 -430.10
PAT 7898.00 8050.00 -1.89 24906.00 15859.00 57.05 34415.00 15292.00 125.05
Equity 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59
PBIDTM(%) 48.42 54.83 -11.69 55.28 47.06 17.46 47.54 34.39 38.25

Zydus Lifesciences Share Price

942.55 3.35 (0.36%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×